These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 1748053)
41. Alterations of blood pressure in type 1 diabetic children and adolescents. Darcan S; Goksen D; Mir S; Serdaroglu E; Buyukinan M; Coker M; Berdeli A; Köse T; Cura A Pediatr Nephrol; 2006 May; 21(5):672-6. PubMed ID: 16568306 [TBL] [Abstract][Full Text] [Related]
42. Diabetic nephropathy and arterial hypertension. The effect of antihypertensive treatment. Parving HH; Andersen AR; Smidt UM; Christiansen JS; Oxenbøll B; Svendsen PA Diabetes; 1983 May; 32 Suppl 2():83-7. PubMed ID: 6400672 [TBL] [Abstract][Full Text] [Related]
43. [Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus]. Lehmann R; Spinas GA Praxis (Bern 1994); 1995 Oct; 84(44):1265-71. PubMed ID: 7491450 [TBL] [Abstract][Full Text] [Related]
45. Ambulatory blood pressure and abnormal albuminuria in type 1 diabetic patients. Hansen KW; Poulsen PL; Mogensen CE Kidney Int Suppl; 1994 Feb; 45():S134-40. PubMed ID: 8158882 [TBL] [Abstract][Full Text] [Related]
46. Autoregulation of glomerular filtration rate during spironolactone treatment in hypertensive patients with type 1 diabetes: a randomized crossover trial. Schjoedt KJ; Christensen PK; Jorsal A; Boomsma F; Rossing P; Parving HH Nephrol Dial Transplant; 2009 Nov; 24(11):3343-9. PubMed ID: 19561152 [TBL] [Abstract][Full Text] [Related]
47. Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Wühl E; Mehls O; Schaefer F; Kidney Int; 2004 Aug; 66(2):768-76. PubMed ID: 15253732 [TBL] [Abstract][Full Text] [Related]
48. Ambulatory blood pressure and urinary albumin excretion in diabetic (non-insulin-dependent and insulin-dependent) hypertensive patients: relationships at baseline and after treatment by the angiotensin converting enzyme inhibitor trandolapril. Bauduceau B; Genès N; Chamontin B; Vaur L; Renault M; Etienne S; Marre M Am J Hypertens; 1998 Sep; 11(9):1065-73. PubMed ID: 9752891 [TBL] [Abstract][Full Text] [Related]
49. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN). Ruggenenti P; Perna A; Mosconi L; Pisoni R; Remuzzi G Kidney Int; 1998 May; 53(5):1209-16. PubMed ID: 9573535 [TBL] [Abstract][Full Text] [Related]
50. Treatment of diabetic nephropathy with angiotensin II receptor antagonist. Lewis EJ; Lewis JB Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737 [TBL] [Abstract][Full Text] [Related]
51. Controversies on the pathogenesis of diabetic angiopathy: which treatment for normotensive adolescents with microalbuminuria and type 1 diabetes? Danne T; Kordonouri O J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():347-63. PubMed ID: 9642665 [TBL] [Abstract][Full Text] [Related]
52. Diabetic nephropathy in insulin-dependent patients. Breyer JA Am J Kidney Dis; 1992 Dec; 20(6):533-47. PubMed ID: 1462980 [TBL] [Abstract][Full Text] [Related]
53. Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention. Baba T; Neugebauer S; Watanabe T Drugs; 1997 Aug; 54(2):197-234. PubMed ID: 9257079 [TBL] [Abstract][Full Text] [Related]
55. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756 [TBL] [Abstract][Full Text] [Related]
56. Twelve shifting paradigms in diabetic renal disease and hypertension. Mogensen CE Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897 [TBL] [Abstract][Full Text] [Related]
57. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy. Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375 [TBL] [Abstract][Full Text] [Related]
58. Predisposition to hypertension: risk factor for nephropathy and hypertension in IDDM. Barzilay J; Warram JH; Bak M; Laffel LM; Canessa M; Krolewski AS Kidney Int; 1992 Apr; 41(4):723-30. PubMed ID: 1513093 [TBL] [Abstract][Full Text] [Related]
59. Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus. McKenna K; Thompson C Scott Med J; 1997 Aug; 42(4):99-104. PubMed ID: 9507584 [TBL] [Abstract][Full Text] [Related]
60. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Nosadini R; Velussi M; Brocco E; Bruseghin M; Abaterusso C; Saller A; Dalla Vestra M; Carraro A; Bortoloso E; Sambataro M; Barzon I; Frigato F; Muollo B; Chiesura-Corona M; Pacini G; Baggio B; Piarulli F; Sfriso A; Fioretto P Diabetes; 2000 Mar; 49(3):476-84. PubMed ID: 10868971 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]